RA0670

antibody from Oursmab

Targeting: SDC1 CD138, SDC, SYND1, syndecan

Western blot (Supportive data in Antibodypedia)

ELISA (Supportive data in Antibodypedia)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0670

Provider

Oursmab

Product name

Indatuximab (Biosimilar Reference Antibody) (SDC1)

Antibody type

Monoclonal

Description

Indatuximab is an investigational antibody-drug conjugate (ADC) developed for the treatment of multiple myeloma and potentially other CD138-positive malignancies. It is engineered by linking a monoclonal antibody to a potent cytotoxic drug via a specialized chemical linker. The antibody component of indatuximab is designed to specifically target CD138 (syndecan-1), a proteoglycan highly expressed on the surface of malignant plasma cells.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Indatuximab (Biosimilar Reference Antibody) (SDC1)-RA0670-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.

ELISA

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

ELISA plate pre-coated Antigen protein, can bind Indatuximab (Biosimilar Reference Antibody) (SDC1)-RA0670 in a linear range of 3.91¨C31 ng/mL.